Literature DB >> 21383019

Toll-like receptor 3 is required for development of retinopathy caused by impaired all-trans-retinal clearance in mice.

Satomi Shiose1, Yu Chen, Kiichiro Okano, Sanhita Roy, Hideo Kohno, Johnny Tang, Eric Pearlman, Tadao Maeda, Krzysztof Palczewski, Akiko Maeda.   

Abstract

Chronic inflammation is an important component that contributes to many age-related neurodegenerative diseases, including macular degeneration. Here, we report a role for toll-like receptor 3 (TLR3) in cone-rod dystrophy (CORD) of mice lacking ATP-binding cassette transporter 4 (ABCA4) and retinol dehydrogenase 8 (RDH8), proteins critical for all-trans-retinal clearance in the retina. Increased expression of toll-like receptor-signaling elements and inflammatory changes were observed in Rdh8(-/-)Abca4(-/-) eyes by RNA expression analysis. Unlike 3-month-old Rdh8(-/-)Abca4(-/-) mice that developed CORD, 6-month-old Tlr3(-/-)Rdh8(-/-)Abca4(-/-) mice did not evidence an abnormal retinal phenotype. Light-induced retinal degeneration in Tlr3(-/-)Rdh8(-/-)Abca4(-/-) mice was milder than that in Rdh8(-/-)Abca4(-/-) mice, and a 2-fold increased TLR3 expression was detected in light-illuminated retinas of Rdh8(-/-)Abca4(-/-) mice compared with nonilluminated retinas. Poly(I-C), a TLR3 ligand, caused caspase-8-independent cellular apoptosis. Whereas poly(I-C) induced retinal cell death in Rdh8(-/-)Abca4(-/-) and WT mice both in vivo and ex vivo, this was not seen in mice lacking Tlr3. Far fewer invasive macrophage/microglial cells in the subretinal space and weaker activation of Muller glial cells were exhibited by Tlr3(-/-)Rdh8(-/-) Abca4(-/-) mice compared with Rdh8(-/-)Abca4(-/-) mice at 3 and 6 months of age, indicating that loss of TLR3 inhibits local inflammation in the retina. Both poly(I-C) and endogenous products emanating from dying/dead retinal cells induced NF-κB and IRF3 activation. These findings demonstrate that endogenous products from degenerating retina stimulate TLR3 that causes cellular apoptosis and retinal inflammation and that loss of TLR3 protects mice from CORD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383019      PMCID: PMC3083179          DOI: 10.1074/jbc.M111.228551

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands.

Authors:  Xiaoxia Z West; Nikolay L Malinin; Alona A Merkulova; Mira Tischenko; Bethany A Kerr; Ernest C Borden; Eugene A Podrez; Robert G Salomon; Tatiana V Byzova
Journal:  Nature       Date:  2010-10-03       Impact factor: 49.962

2.  Variation in complement factor 3 is associated with risk of age-related macular degeneration.

Authors:  Julian B Maller; Jesen A Fagerness; Robyn C Reynolds; Benjamin M Neale; Mark J Daly; Johanna M Seddon
Journal:  Nat Genet       Date:  2007-09-02       Impact factor: 38.330

3.  The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration.

Authors:  Michela Deleidi; Penelope J Hallett; James B Koprich; Chee-Yeun Chung; Ole Isacson
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

4.  A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration.

Authors:  Zhenglin Yang; Nicola J Camp; Hui Sun; Zongzhong Tong; Daniel Gibbs; D Joshua Cameron; Haoyu Chen; Yu Zhao; Erik Pearson; Xi Li; Jeremy Chien; Andrew Dewan; Jennifer Harmon; Paul S Bernstein; Viji Shridhar; Norman A Zabriskie; Josephine Hoh; Kimberly Howes; Kang Zhang
Journal:  Science       Date:  2006-10-19       Impact factor: 47.728

Review 5.  Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents.

Authors:  Gabriel H Travis; Marcin Golczak; Alexander R Moise; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

6.  MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity.

Authors:  David G Ryan; Michelle Oliveira-Fernandes; Robert M Lavker
Journal:  Mol Vis       Date:  2006-10-17       Impact factor: 2.367

7.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.

Authors:  Bert Gold; Joanna E Merriam; Jana Zernant; Lisa S Hancox; Andrew J Taiber; Karen Gehrs; Kevin Cramer; Julia Neel; Julie Bergeron; Gaetano R Barile; R Theodore Smith; Gregory S Hageman; Michael Dean; Rando Allikmets
Journal:  Nat Genet       Date:  2006-03-05       Impact factor: 38.330

8.  Complement C3 variant and the risk of age-related macular degeneration.

Authors:  John R W Yates; Tiina Sepp; Baljinder K Matharu; Jane C Khan; Deborah A Thurlby; Humma Shahid; David G Clayton; Caroline Hayward; Joanne Morgan; Alan F Wright; Ana Maria Armbrecht; Baljean Dhillon; Ian J Deary; Elizabeth Redmond; Alan C Bird; Anthony T Moore
Journal:  N Engl J Med       Date:  2007-07-18       Impact factor: 91.245

9.  Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages.

Authors:  Jaimie Hoh Kam; Eva Lenassi; Glen Jeffery
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

10.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Authors:  Milan Fiala; Philip T Liu; Araceli Espinosa-Jeffrey; Mark J Rosenthal; George Bernard; John M Ringman; James Sayre; Laura Zhang; Justin Zaghi; Sheila Dejbakhsh; Ben Chiang; James Hui; Michelle Mahanian; Anita Baghaee; Pamela Hong; John Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

View more
  30 in total

1.  Reduced photoreceptor death and improved retinal function during retinal degeneration in mice lacking innate immunity adaptor protein MyD88.

Authors:  Sarah Syeda; Amit K Patel; Tinthu Lee; Abigail S Hackam
Journal:  Exp Neurol       Date:  2015-02-25       Impact factor: 5.330

Review 2.  Chemistry of the retinoid (visual) cycle.

Authors:  Philip D Kiser; Marcin Golczak; Krzysztof Palczewski
Journal:  Chem Rev       Date:  2013-07-11       Impact factor: 60.622

3.  Zika Virus Depletes Neural Progenitors in Human Cerebral Organoids through Activation of the Innate Immune Receptor TLR3.

Authors:  Jason Dang; Shashi Kant Tiwari; Gianluigi Lichinchi; Yue Qin; Veena S Patil; Alexey M Eroshkin; Tariq M Rana
Journal:  Cell Stem Cell       Date:  2016-05-06       Impact factor: 24.633

4.  Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Authors:  Shravan K Chintala; Nahrain Putris; Mason Geno
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-06       Impact factor: 4.799

Review 5.  Retinal photodamage mediated by all-trans-retinal.

Authors:  Tadao Maeda; Marcin Golczak; Akiko Maeda
Journal:  Photochem Photobiol       Date:  2012-04-24       Impact factor: 3.421

6.  Posttranslational modifications of the photoreceptor-specific ABC transporter ABCA4.

Authors:  Yaroslav Tsybovsky; Benlian Wang; Faraz Quazi; Robert S Molday; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2011-07-08       Impact factor: 3.162

7.  A microparticle/hydrogel combination drug-delivery system for sustained release of retinoids.

Authors:  Song-Qi Gao; Tadao Maeda; Kiichiro Okano; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-19       Impact factor: 4.799

8.  CCL3 production by microglial cells modulates disease severity in murine models of retinal degeneration.

Authors:  Hideo Kohno; Tadao Maeda; Lindsay Perusek; Eric Pearlman; Akiko Maeda
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

9.  A novel protective role for the innate immunity Toll-Like Receptor 3 (TLR3) in the retina via Stat3.

Authors:  Amit K Patel; Abigail S Hackam
Journal:  Mol Cell Neurosci       Date:  2014-09-28       Impact factor: 4.314

10.  QLT091001, a 9-cis-retinal analog, is well-tolerated by retinas of mice with impaired visual cycles.

Authors:  Tadao Maeda; Zhiqian Dong; Hui Jin; Osamu Sawada; Songqi Gao; Deepank Utkhede; Wendy Monk; Grazyna Palczewska; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-17       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.